查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1873980

腺苷三磷酸（ATP）拭子检测市场

Adenosine Triphosphate (ATP) Swab Test Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

2024年腺苷三磷酸（ATP）拭子检测市场价值约2.9862亿美元，预计到2031年将达到5.3516亿美元。此成长意味着2031年至2031年间的年复合成长率（CAGR）为9.2%。 ATP拭子检测市场的一个重要趋势是基于腺苷酸（A3）浓度的现代无菌监测系统的发展。

腺苷三磷酸（ATP）拭子检测市场分析

医疗相关感染（HAI）发生率的不断上升是推动ATP拭子检测需求成长的主要因素。例如，世界卫生组织（WHO）于2022年5月发布了首份全球感染预防与控制报告，指出在急性护理医院的每100名患者中，高收入国家有7名患者，中低收入国家有15名患者在住院期间面临感染至少一种HAI的风险。平均而言，每10名HAI患者中就有1名会因此死亡。 HAI的高发生率预计将积极促进ATP拭子检测的普及，从而推动ATP拭子检测市场的成长。

腺苷三磷酸（ATP）拭子检测市场概览

ATP拭子检测市场的扩张主要受多种关键因素驱动，包括医院感染（HAI）发生率的上升和人们对食品安全的日益重视。然而，ATP拭子检测的限制也对市场成长构成挑战。全球ATP拭子检测市场按地区划分为北美、欧洲、亚太、中东和非洲以及南美和中美洲。在北美，美国是ATP拭子检测的最大市场，这主要得益于主要市场参与者的存在以及医院感染的日益普遍。此外，持续的产品创新预计将进一步促进北美ATP拭子检测市场的成长。

预计亚太地区将成为ATP拭子检测市场成长最快的地区。医疗保健和食品饮料行业的快速扩张，以及亚太地区领先市场参与者在卫生监测系统方面不断加大投资和创新，有望推动市场成长。

战略洞察

腺苷三磷酸（ATP）拭子检测市场的驱动因素和机会

食源性疾病和污染事件的增加有利于市场成长

世界卫生组织报告称，每年全球因不安全食品导致6亿例食源性疾病和42万人死亡，其中5岁以下儿童占死亡人数的30%。此外，世卫组织估计，不安全食品的消费每年导致3,300万健康寿命的损失，而这很可能是个低估的数字。受污染的食物可引发200多种疾病，显着加重了全球疾病负担和死亡率。 ATP检测在食品生产环境中至关重要，因为清洁不当会促进微生物滋生。食品也可能为细菌、霉菌和酵母提供营养，导致它们大量繁殖。因此，ATP检测可作为早期预警系统，确保食品环境的卫生。食源性疾病的高发生率增加了人们对食品安全的需求，预计这将推动ATP拭子检测市场在预测期内成长。

日益重视病人安全与照护－ATP拭子检测市场的客製化机会

医院感染是导致住院病患死亡和发病的主要原因之一，对全球病患和医疗系统带来额外的经济和情绪负担。因此，各国政府和医疗卫生机构正将预防医院感染的安全计画列为优先事项。例如，2024年，第七十二届世界卫生大会通过了「全球病人安全行动」的WHA72.6号决议，该决议要求制定全球病人安全行动计画。 《2021-2030年全球病人安全行动计画》为各利害关係人进行病人安全合作提供了全面的架构。预计此类政策的实施将为ATP拭子检测市场创造可观的成长机会。

腺苷三磷酸（ATP）拭子检测市场区隔分析

ATP拭子检测市场分析的关键细分市场包括类型和应用。

  • 按类型划分，ATP拭子检测市场分为游离ATP检测和微生物ATP检测，其中游离ATP检测部分在2023年占据更大的市场份额。
  • 从应用角度来看，市场分为製药和生物技术公司、食品和饮料、医院和诊断实验室以及学术和研究机构，其中製药和生物技术公司在 2023 年将引领市场。

腺苷三磷酸（ATP）拭子检测的地理市场份额分析

ATP拭子检测市场报告的地理分析分为五个区域：北美、亚太、欧洲、中东和非洲以及南美/南美和中美洲。

北美一直是ATP拭子检测市场的主导地区。根据美国疾病管制与预防中心（CDC）估计，美国医院每年约有170万例医院感染病例和9.9万例相关死亡病例。医院感染负担的加重预计将推动北美对ATP拭子检测的需求。同样，食源性疾病和污染发生率的上升也促进了市场成长。预计未来几年，亚太地区的复合年增长率将最高。

腺苷三磷酸（ATP）拭子检测市场报告范围

腺苷三磷酸（ATP）拭子检测市场的最新发展

ATP拭子检测市场评估是基于从一手和二手研究中收集的定性和定量资料，包括重要的企业出版物、协会资料和资料库。 ATP拭子检测市场的主要发展包括：

  • Ecolab食品饮料北美公司与食品安全和环境快速诊断检测技术领域的领导企业Hygiena, LLC达成合作。此次合作将为食品饮料产业提供一套全新的卫生监测方案，以加强其食品安全措施。 （资料来源：Hygiena LLC，2020年新闻稿，腺苷三磷酸（ATP）拭子检测）

腺苷三磷酸（ATP）拭子检测市场报告的覆盖范围和交付成果

题为《三磷酸腺苷（ATP）拭子检测市场规模及预测（2021-2031）》的报告对市场进行了全面分析，涵盖以下领域：

  • 涵盖范围内所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态，例如驱动因素、限制因素和关键机会
  • 未来主要趋势
  • 详细的PEST/波特五力模型与SWOT分析
  • 全球及区域市场分析，重点在于关键趋势、主要参与者、法规及最新发展。
  • 产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展动态
  • 深入的公司概况

目录

第一章：引言

第二章：三磷酸腺苷（ATP）拭子检测市场及主要结论

第三章：研究方法

  • 覆盖范围
  • 二手研究
  • 初步研究

第四章：全球三磷酸腺苷（ATP）拭子检测市场及市场概况

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 欧洲 PEST 分析
    • 亚太地区及PEST分析
    • 中东和非洲以及 PEST 分析
    • 南美洲和中美洲以及 PEST 分析
  • 专家意见

第五章：三磷酸腺苷（ATP）拭子检测市场及主要市场动态

  • 市场驱动因素
    • 医疗相关感染（HAI）盛行率上升
    • 日益重视食品安全
  • 市场约束
    • ATP拭子检测的局限性
  • 市场机会
    • 增加对病人安全和照护的投入
  • 未来趋势
    • 基于腺苷酸（A3）浓度的现代无菌监测系统的开发
  • 影响分析

第六章：三磷酸腺苷（ATP）拭子检测市场及全球分析

  • 全球腺苷三磷酸（ATP）拭子检测市场收入预测与分析
  • 全球腺苷三磷酸（ATP）拭子检测市场（依地域划分）－预测与分析
  • 关键参与者的市场定位

第七章：腺苷三磷酸（ATP）拭子检测市场分析及至2031年的预测与类型

  • 概述
  • 2024 年和 2031 年全球腺苷三磷酸 (ATP) 拭子检测市场份额（按类型划分）(%)
  • 游离ATP检测
    • 概述
    • 免费ATP检测市场收入及至2031年预测
  • 微生物ATP检测
    • 概述
      • 微生物ATP检测：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测

第八章：腺苷三磷酸（ATP）拭子检测市场分析及至2031年的预测与应用

  • 概述
  • 2024 年和 2031 年全球腺苷三磷酸 (ATP) 拭子检测市场份额（按应用领域划分）
  • 製药和生物技术公司
    • 概述
      • 製药和生物製药公司：三磷酸腺苷 (ATP) 拭子检测市场及收入预测（至 2031 年）
    • 食品和饮料
      • 概述
      • 食品饮料：三磷酸腺苷（ATP）拭子检测市场及收入预测（至2031年）
    • 医院和诊断实验室
      • 概述
      • 医院和诊断实验室：三磷酸腺苷 (ATP) 拭子检测市场及收入预测（至 2031 年）
    • 学术和研究机构
      • 概述
      • 学术及研究机构：三磷酸腺苷（ATP）拭子检测市场及收入预测（至2031年）

第九章：腺苷三磷酸（ATP）拭子检测分析及至2031年的预测及地理分析

  • 北美：三磷酸腺苷 (ATP) 拭子检测市场
    • 概述
    • 北美：三磷酸腺苷（ATP）拭子检测市场－收入及至2031年的预测
    • 北美：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
    • 北美：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 北美：2024 年和 2031 年按国家分類的三磷酸腺苷 (ATP) 拭子检测市场（%）
    • 美国：三磷酸腺苷（ATP）拭子检测及收入预测（至2031年）
      • 美国：三磷酸腺苷（ATP）拭子检测及收入预测（至2031年）
      • 美国：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 美国：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 加拿大：三磷酸腺苷（ATP）拭子检测及收入预测（至2031年）
      • 加拿大：三磷酸腺苷（ATP）拭子检测及收入预测（至2031年）
      • 加拿大：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
      • 加拿大：腺苷三磷酸（ATP）拭子检测市场，依最终用户和收入划分，并预测至2031年
    • 墨西哥：三磷酸腺苷（ATP）拭子检测及收入预测（至2031年）
      • 墨西哥：三磷酸腺苷（ATP）拭子检测及收入预测（至2031年）
      • 墨西哥：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 墨西哥：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
  • 欧洲：三磷酸腺苷（ATP）拭子检测市场
    • 概述
    • 欧洲：三磷酸腺苷（ATP）拭子检测市场－收入及至2031年的预测
    • 欧洲：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
    • 欧洲：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 欧洲：2024 年及 2031 年各国腺苷三磷酸 (ATP) 拭子检测市场规模（%）
    • 德国：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 德国：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 德国：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 德国：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 英国：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 英国：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 英国：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 英国：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 法国：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 法国：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 法国：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 法国：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 西班牙：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 西班牙：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 西班牙：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 西班牙：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 义大利：腺苷三磷酸（ATP）拭子检测市场、收入及至2031年的预测
      • 义大利：腺苷三磷酸（ATP）拭子检测市场、收入及至2031年的预测
      • 义大利：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 义大利：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 欧洲其他地区：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 欧洲其他地区：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 欧洲其他地区：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 欧洲其他地区：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
  • 亚太地区：三磷酸腺苷（ATP）拭子检测市场
    • 概述
    • 亚太地区：三磷酸腺苷（ATP）拭子检测市场－收入及至2031年的预测
    • 亚太地区：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
    • 亚太地区：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 亚太地区：按国家/地区分類的腺苷三磷酸 (ATP) 拭子检测市场，2024 年和 2031 年（%）
    • 中国：三磷酸腺苷（ATP）拭子检测市场及收入预测（至2031年）
      • 中国：三磷酸腺苷（ATP）拭子检测市场及收入预测（至2031年）
      • 中国：腺苷三磷酸（ATP）拭子检测市场，依应用、所得划分及至2031年预测
      • 中国：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 日本：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 日本：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 日本：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 日本：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 印度：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 印度：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 印度：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 印度：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 韩国：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 韩国：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 韩国：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 韩国：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 澳洲：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 澳洲：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 澳洲：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 澳洲：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 亚太其他地区：三磷酸腺苷（ATP）拭子检测市场及收入预测（至2031年）
      • 亚太其他地区：三磷酸腺苷（ATP）拭子检测市场及收入预测（至2031年）
      • 亚太其他地区：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 亚太其他地区：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
  • 中东和非洲：三磷酸腺苷 (ATP) 拭子检测市场
    • 概述
    • 中东和非洲：三磷酸腺苷（ATP）拭子检测市场－收入及至2031年的预测
    • 中东和非洲腺苷三磷酸（ATP）拭子检测市场，按产品和收入划分，并预测至2031年
    • 中东和非洲腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 中东和非洲腺苷三磷酸 (ATP) 拭子检测市场（按国家/地区划分），2024 年和 2031 年（%）
    • 沙乌地阿拉伯：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 沙乌地阿拉伯：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 沙乌地阿拉伯腺苷三磷酸（ATP）拭子检测市场，依应用、收入划分及至2031年预测
      • 沙乌地阿拉伯腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 阿联酋：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 阿联酋：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 阿联酋：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 阿联酋：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 南非：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 南非：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 南非腺苷三磷酸（ATP）拭子检测市场，依应用、所得划分及至2031年预测
      • 南非腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 中东和非洲其他地区：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 中东和非洲其他地区：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 中东和非洲其他地区腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 中东和非洲其他地区：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
  • 南美洲和中美洲：三磷酸腺苷 (ATP) 拭子检测市场
    • 概述
    • 南美洲和中美洲：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
    • 南美洲和中美洲：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
    • 南美洲和中美洲：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 南美洲和中美洲：按国家分類的腺苷三磷酸 (ATP) 拭子检测市场，2024 年和 2031 年（%）
    • 巴西：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 巴西：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 巴西：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 巴西：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 阿根廷：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 阿根廷：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 阿根廷：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 阿根廷：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年
    • 南美洲和中美洲其他地区：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 南美洲和中美洲其他地区：三磷酸腺苷（ATP）拭子检测市场、收入及至2031年的预测
      • 南美洲和中美洲其他地区：腺苷三磷酸（ATP）拭子检测市场，按应用和收入划分，并预测至2031年
      • 南美洲和中美洲其他地区：腺苷三磷酸（ATP）拭子检测市场，按类型和收入划分，并预测至2031年

第十章：新冠肺炎疫情对全球三磷酸腺苷（ATP）拭子检测市场的影响

  • 北美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲和中美洲

第十一章：三磷酸腺苷（ATP）拭子检测市场及产业概况

  • 概述
  • 腺苷三磷酸（ATP）拭子检测市场近期成长策略

第十二章：公司简介

  • 3M
  • Hygiena, LLC
  • Charm Sciences
  • Kikkoman Biochemifa Co
  • Neogen Corporation
  • Ecolab
  • Ruhof Healthcare Corporation
  • LuminUltra Technologies Ltd.
  • MERCK KGaA
  • Promicol
  • PCE Instruments
  • Promega Corporation
  • CHARLES RIVER LABORATORIES, INC

第十三章：附录

简介目录
Product Code: TIPRE00014433

The market for Adenosine Triphosphate (ATP) Swab Tests was valued at approximately US$ 298.62 million in 2024 and is projected to reach US$ 535.16 million by 2031. This growth represents a compound annual growth rate (CAGR) of 9.2% through 2031 - 2031. A significant trend in the ATP Swab Test Market is the development of modern sterility monitoring systems based on Adenylate (A3) concentration.

Analysis of the Adenosine Triphosphate (ATP) Swab Test Market

The increasing incidence of Healthcare-Associated Infections (HAIs) is a major factor driving the demand for ATP Swab Tests. For example, the World Health Organization (WHO) released its first global report on Infection Prevention and Control in May 2022, indicating that among every 100 patients in acute-care hospitals, 7 in high-income countries and 15 in low- and middle-income countries are at risk of acquiring at least one HAI during their hospital stay. On average, 1 in 10 patients affected by HAIs will die as a result. This significant prevalence of HAIs is expected to positively influence the adoption of ATP swab tests, thereby propelling the growth of the ATP Swab Test market.

Overview of the Adenosine Triphosphate (ATP) Swab Test Market

The expansion of the ATP Swab Test market is driven by several key factors, including the rising incidence of HAIs and a growing focus on food safety. However, the limitations associated with ATP swab tests pose a challenge to market growth. The global ATP Swab Test market is categorized by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the United States represents the largest market for ATP swab tests, driven by the presence of major market players and the increasing prevalence of HAIs. Additionally, ongoing product innovations are expected to further enhance the growth of the ATP Swab Test market in North America.

The Asia Pacific region is anticipated to experience the fastest growth in the ATP Swab Test market. The rapid expansion of the healthcare and food & beverage sectors, along with increased investments and innovations in hygiene monitoring systems by leading market players in Asia Pacific, is likely to drive market growth.

Strategic Insights

Drivers and Opportunities in the Adenosine Triphosphate (ATP) Swab Test Market

Increasing Incidence of Foodborne Illnesses and Contamination Favoring Market Growth

The WHO reports that unsafe food leads to 600 million cases of foodborne diseases and 420,000 deaths globally each year, with children under five accounting for 30% of these fatalities. Furthermore, WHO estimates that unsafe food consumption results in a loss of 33 million years of healthy life annually, likely an underestimation. Contaminated food can cause over 200 diseases, significantly contributing to global disease burden and mortality. ATP testing is vital in food production settings, as improper cleaning can foster microbial growth. Food can also provide nutrients for bacteria, mold, and yeast, leading to their proliferation. Thus, ATP testing serves as an early warning system to ensure hygienic food environments. The high prevalence of foodborne diseases is increasing the demand for food safety, which is expected to drive the ATP swab test market during the forecast period.

Growing Focus on Patient Safety and Care - Customization Opportunities in the ATP Swab Test Market

HAIs are a leading cause of significant mortality and morbidity among hospital patients, imposing additional financial and emotional burdens on patients and healthcare systems worldwide. Consequently, governments and healthcare authorities are prioritizing safety programs to prevent HAIs. For instance, in 2024, the Seventy-second World Health Assembly adopted resolution WHA72.6 on "Global action on patient safety," which mandates the creation of a global patient safety action plan. The Global Patient Safety Action Plan for 2021-2030 provides a comprehensive framework for stakeholders to collaborate on patient safety initiatives. The implementation of such policies is expected to create attractive growth opportunities for the ATP Swab Test market.

Segmentation Analysis of the Adenosine Triphosphate (ATP) Swab Test Market

Key segments contributing to the ATP Swab Test Market analysis include type and application.

  • By type, the ATP Swab Test market is divided into Free ATP Test and Microbial ATP Test, with the Free ATP Test segment holding a larger market share in 2023.
  • In terms of application, the market is segmented into pharmaceutical and biotechnology companies, food and beverage, hospitals and diagnostic laboratories, and academic and research institutions, with the pharmaceutical and biotechnology companies segment leading the market in 2023.

Geographical Market Share Analysis for Adenosine Triphosphate (ATP) Swab Test

The geographical analysis of the ATP Swab Test Market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America has been the leading region in the ATP Swab Test Market. The Centers for Disease Control (CDC) estimates that HAIs account for approximately 1.7 million infections and 99,000 associated deaths annually in American hospitals. The increasing burden of HAIs is expected to drive demand for ATP Swab Tests in North America. Similarly, the rising incidence of foodborne diseases and contamination is also contributing to market growth. The Asia Pacific region is projected to experience the highest CAGR in the coming years.

Scope of the Adenosine Triphosphate (ATP) Swab Test Market Report

Recent Developments in the Adenosine Triphosphate (ATP) Swab Test Market

The ATP Swab Test Market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Notable developments in the ATP Swab Test market include:

  • Ecolab Food and Beverage North America partnered with Hygiena, LLC, a leader in rapid food safety and environmental diagnostic testing technology. This collaboration will provide the food and beverage industry with a new Hygiene Monitoring Program to enhance their Food Safety initiatives. (Source: Adenosine Triphosphate (ATP) Swab Test Hygiena LLC, Press Release, 2020)

Coverage and Deliverables of the Adenosine Triphosphate (ATP) Swab Test Market Report

The report titled "Adenosine Triphosphate (ATP) Swab Test Market Size and Forecast (2021-2031)" offers a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter's Five Forces and SWOT analysis
  • Global and regional market analysis highlighting key trends, major players, regulations, and recent developments
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments
  • In-depth company profiles

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Adenosine Triphosphate (ATP) Swab Test Market and ByType
    • 1.3.2 Global Adenosine Triphosphate (ATP) Swab Test Market and By Application
    • 1.3.3 Global Adenosine Triphosphate (ATP) Swab Test Market and By Geography

2. Adenosine Triphosphate (ATP) Swab Test Marketand Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Adenosine Triphosphate (ATP) Swab Test Market and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific and PEST Analysis
    • 4.2.4 Middle East and Africaand PEST Analysis
    • 4.2.5 South and Central America and PEST Analysis
  • 4.3 Expert Opinion

5. Adenosine Triphosphate (ATP) Swab Test Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Healthcare-Associated Infections (HAI)
    • 5.1.2 Increasing Emphasis on Food Safety
  • 5.2 Market Restraint
    • 5.2.1 Limitations of ATP Swab Tests
  • 5.3 Market Opportunity
    • 5.3.1 Growing Spending on Patient Safety and Care
  • 5.4 Future Trend
    • 5.4.1 Development of Adenylate (A3) Concentration Based Modern Sterility Monitoring System
  • 5.5 Impact Analysis

6. Adenosine Triphosphate (ATP) Swab Test Market and Global Analysis

  • 6.1 Global Adenosine Triphosphate (ATP) Swab Test Market Revenue Forecast and Analysis
  • 6.2 Global Adenosine Triphosphate (ATP) Swab Test Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Adenosine Triphosphate (ATP) Swab Test Market Analysis and Forecasts To 2031 andType

  • 7.1 Overview
  • 7.2 Global Adenosine Triphosphate (ATP) Swab Test Market Share by Type2024 and 2031 (%)
  • 7.3 Free ATP Test
    • 7.3.1 Overview
    • 7.3.2 Free ATP Test Market Revenue and Forecast to 2031 (US$ Mn)
  • 7.4 Microbial ATP Test
    • 7.4.1 Overview
      • 7.4.1.1 Microbial ATP Test: Adenosine Triphosphate (ATP) Swab Test Marketand Revenue and Forecast to 2031 (US$ Million)

8. Adenosine Triphosphate (ATP) Swab Test Market Analysis and Forecasts To 2031 and Application

  • 8.1 Overview
  • 8.2 Global Adenosine Triphosphate (ATP) Swab Test Market Share by Application 2024 and 2031 (%)
  • 8.3 Pharmaceutical and Biotechnology Company
    • 8.3.1 Overview
      • 8.3.1.1 Pharmaceutical and biopharmaceutical companies: Adenosine Triphosphate (ATP) Swab Test Marketand Revenue and Forecast to 2031 (US$ Million)
    • 8.3.2 Food and Beverage
      • 8.3.2.1 Overview
      • 8.3.2.2 Food and Beverage: Adenosine Triphosphate (ATP) Swab Test Marketand Revenue and Forecast to 2031 (US$ Million)
    • 8.3.3 Hospitals and Diagnostics Laboratories
      • 8.3.3.1 Overview
      • 8.3.3.2 Hospitals and Diagnostics Laboratories: Adenosine Triphosphate (ATP) Swab Test Marketand Revenue and Forecast to 2031 (US$ Million)
    • 8.3.4 Academic and Research Institutions
      • 8.3.4.1 Overview
      • 8.3.4.2 Academic and Research Institutions: Adenosine Triphosphate (ATP) Swab Test Marketand Revenue and Forecast to 2031 (US$ Million)

9. Adenosine Triphosphate (ATP) Swab Test Analysis and Forecasts To 2031 and Geographical Analysis

  • 9.1 North America: Adenosine Triphosphate (ATP) Swab Test Market
    • 9.1.1 Overview
    • 9.1.2 North America: Adenosine Triphosphate (ATP) Swab Test Market, - Revenue and Forecast to 2031 (USD Million)
    • 9.1.3 North America: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 9.1.4 North America: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.1.5 North America: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2024 and 2031 (%)
    • 9.1.6 US: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.6.1 US: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.6.2 US: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.1.6.3 US: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.1.7 Canada: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.7.1 Canada: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.7.2 Canada: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
      • 9.1.7.3 Canada: Adenosine Triphosphate (ATP) Swab Test Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 9.1.8 Mexico: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.8.1 Mexico: Adenosine Triphosphate (ATP) Swab Test and Revenue and Forecast to 2031 (USD Million)
      • 9.1.8.2 Mexico: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.1.8.3 Mexico: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
  • 9.2 Europe: Adenosine Triphosphate (ATP) Swab Test Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Adenosine Triphosphate (ATP) Swab Test Market, - Revenue and Forecast to 2031 (USD Million)
    • 9.2.3 Europe: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
    • 9.2.4 Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.5 Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2024 and 2031 (%)
    • 9.2.6 Germany: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.6.1 Germany: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.6.2 Germany: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.6.3 Germany: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.7 UK: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.7.1 UK: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.7.2 UK: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.7.3 UK: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.8 France: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.8.1 France: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.8.2 France: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.8.3 France: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.9 Spain: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.9.1 Spain: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.9.2 Spain: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.9.3 Spain: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.10 Italy: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.10.1 Italy: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.10.2 Italy: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.10.3 Italy: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.2.11 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.11.1 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.2.11.2 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.2.11.3 Rest of Europe: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
  • 9.3 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, - Revenue and Forecast to 2031 (USD Million)
    • 9.3.3 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
    • 9.3.4 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.5 Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2024 and 2031 (%)
    • 9.3.6 China: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.6.1 China: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.6.2 China: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.6.3 China: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.7 Japan: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.7.1 Japan: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.7.2 Japan: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.7.3 Japan: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.8 India: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.8.1 India: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.8.2 India: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.8.3 India: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.9 South Korea: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.9.1 South Korea: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.9.2 South Korea: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.9.3 South Korea: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.10 Australia: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.10.1 Australia: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.10.2 Australia: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.10.3 Australia: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
    • 9.3.11 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.11.1 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.3.11.2 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, By Application and Revenue and Forecast to 2031 (USD Million)
      • 9.3.11.3 Rest of Asia Pacific: Adenosine Triphosphate (ATP) Swab Test Market, by Typeand Revenue and Forecast to 2031 (USD Million)
  • 9.4 Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market
    • 9.4.1 Overview
    • 9.4.2 Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.4.3 Middle East and Africa Adenosine Triphosphate (ATP) Swab Test Market, by Products and Revenue and Forecast to 2031 (USD Million)
    • 9.4.4 Middle East and Africa Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.4.5 Middle East and Africa Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2024 and 2031 (%)
    • 9.4.6 Saudi Arabia: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.6.1 Saudi Arabia: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.6.2 Saudi Arabia Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.4.6.3 Saudi Arabia Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.4.7 UAE: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.7.1 UAE: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.7.2 UAE: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.4.7.3 UAE: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.4.8 South Africa: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.8.1 South Africa: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.8.2 South Africa Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.4.8.3 South Africa Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.4.9 Rest of Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.9.1 Rest of Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.4.9.2 Rest of Middle East and Africa Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.4.9.3 Rest of Middle East and Africa: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
  • 9.5 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
    • 9.5.3 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 9.5.4 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.5.5 South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Country, 2024 and 2031 (%)
    • 9.5.6 Brazil: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.6.1 Brazil: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.6.2 Brazil: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.5.6.3 Brazil: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.5.7 Argentina: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.7.1 Argentina: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.7.2 Argentina: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.5.7.3 Argentina: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)
    • 9.5.8 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.8.1 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market and Revenue and Forecast to 2031 (USD Million)
      • 9.5.8.2 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 9.5.8.3 Rest of South and Central America: Adenosine Triphosphate (ATP) Swab Test Market, by Type and Revenue and Forecast to 2031 (USD Million)

10. Impact Of COVID-19 Pandemic on Global Adenosine Triphosphate (ATP) Swab Test Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Adenosine Triphosphate (ATP) Swab Test Market andIndustry Landscape

  • 11.1 Overview
  • 11.2 Recent Growth Strategies in The Adenosine Triphosphate (ATP) Swab Test Market

12. Company Profiles

  • 12.1 3M
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Hygiena, LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Charm Sciences
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Kikkoman Biochemifa Co
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Neogen Corporation
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Ecolab
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Ruhof Healthcare Corporation
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 LuminUltra Technologies Ltd.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 MERCK KGaA
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Promicol
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 PCE Instruments
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Promega Corporation
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 CHARLES RIVER LABORATORIES, INC
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms, Adenosine Triphosphate (ATP) Swab Test Market